Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Stovner LJ et al. – After the triptans, a calcitonin gene–related peptide blocker (telcagepant) is the first acute medicine that has been developed primarily for treatment of acute migraine. Otherwise, the new drugs have been developed first for other purposes, like anticonvulsants, antihypertensives and antidepressants used for migraine prophylaxis. For acute attacks, a new way to administer a traditional drug like dihydroergotamine is under way, and documentation of efficacy in migraine has been gained for some commonly used painkillers and anti–inflammatory drugs, and for some herbal extracts. Based on insights into the basic pathophysiological mechanisms of the disorder, some drugs have been developed which seem promising in early phase II studies (NOS inhibitors and 5HT1F–receptor agonists). In the future, development and enhancements of existing medicines must be accompanied by increased efforts to develop truly new migraine drugs based on knowledge of the pathophysiology if one wishes to reduce substantially the great burden migraine poses on patients and society.

Related Articles

Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09    Relevance Score: 69%

CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09    Relevance Score: 68%

Controversies in migraine
Nurse Prescribing, 10/09/09    Relevance Score: 68%

Ankle-Brachial Index, a Screening for Peripheral Obstructive Arterial Disease, and Migraine – A Controlled Study
Headache: The Journal of Head and Face Pain, 10/07/09    Relevance Score: 68%

Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09    Relevance Score: 67%

Today in Headache...keeping you current

CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09

Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting
The Journal of Headache and Pain, 11/10/09

Prevalence of Depression Symptoms in Outpatients with a Complaint of Headache
Journal of the American Board of Family Medicine, 11/09/09

Today in Pain Medicine...keeping you current

Treatment of pathologic spinal fractures with combined radiofrequency ablation and balloon kyphoplasty
World Journal of Surgical Oncology, 11/20/09

When should you consider implanted nerve stimulators for lower back pain?
APCToday, 11/20/09

Guidelines for the proper use of epidural steroid injections for the chronic pain patient
Techniques in Regional Anesthesia and Pain Management, 11/20/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address